Table 2.
Drug use during follow-upa
| Drug | Placebo | Pravastatin | Fosinopril | Pravastatin + fosinopril |
|---|---|---|---|---|
| Total other antibiotics | 84 (50%) | 88 (56%) | 79 (49%) | 94 (56%) |
| Other antibiotics used for UTI treatment (amoxicillin, amoxicillin/clavulanate, quinolones) | 47 (28%) | 44 (28%) | 44 (28%) | 54 (32%) |
| NSAIDs | 86 (51%) | 88 (56%) | 85 (53%) | 98 (58%) |
| Drugs for acid-related disorders | 33 (20%) | 33 (21%) | 39 (24%) | 38 (23%) |
| Antifungals for dermatological use | 32 (19%) | 33 (21%) | 36 (23%) | 40 (24%) |
Abbreviations: NSAIDs, non-steroidal anti-inflammatory drugs; UTI, urinary tract infection.
aData presented as number of persons receiving at least one prescription during follow-up.